A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

NCT03716011 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

2700

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: EXCROSSAL

Sponsor

JW Medical Systems Ltd